Phase II Trial of ASM8 in Asthma Commences
7th
Dec 10
Release Date: 07/12/2010 12:00am
Pharmaxis today announced it had enrolled the first subjects into a Phase II clinical trial evaluating the new asthma drug, ASM8, in patients with allergic asthma.
Categories: News and Media